MRI and Mammography Surveillance of Women at Increased Risk for Breast Cancer. Recommendations Using an Evidence-based Approach

Academic Radiology

Volumn 15, Issue 12, 2008, Pages 1590-1595

  Granader, Elon J ^a   Dwamena, Ben ^a,b   Carlos, Ruth C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

BRCA; breast cancer; Magnetic resonance imaging (MRI); mammography; surveillance

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; EVIDENCE BASED PRACTICE; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; GENETIC PREDISPOSITION TO DISEASE; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; POPULATION SURVEILLANCE; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 55349103791     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2008.06.006     Document Type: Article

References (17)

1. Saslow D., Boetes C., Burke W., et al. American Cancer Society Guidelines for breast screening with mri as an adjunct to mammography. CA Cancer J Clin 57 (2007) 75-89
2. Sheehan J.J., Ridge C.A., Ward E.V., et al. The process of evidence-based practice in radiology: an introduction. Acad Radiol 14 (2007) 385-388
3. Leach M.O., Boggis C.R., Dixon A.K., et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365 (2005) 1769-1778
4. Kuhl C.K., Schrading S., Leutner C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23 (2005) 8469-8476
5. Kriege M., Brekelmans C.T.M., Obdeijn I.M., et al. Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. Breast Cancer Res Treat 100 (2006) 109-119
6. Kriege M., Brekelmans C.T.M., Boetes C., et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351 (2004) 427-437
7. Stoutjesdijk M.J., Boetes C., Jager G.J., et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 93 (2001) 1095-1102
8. Lehman C.D., Blume J.D., Weatherall P., et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103 (2005) 1898-1905
9. Lehman C.D., Isaacs C., Schnall M.D., et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 244 (2007) 381-388
10. Warner E., Plewes D.B., Shumak R.S., et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19 (2001) 3524-3531
11. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292 (2004) 1317-1325
12. Centre for Evidence Based Medicine, University of Oxford. Levels of evidence and grades of recommendations. www.cebm.net/levels_of_evidence.asp Accessed August 16, 2007
13. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clinical Trials 7 (1986) 177-188
14. Mosteller F., and Colditz G.A. Understanding research synthesis (meta analysis). Annu Rev Public Health 17 (1996) 1-23
15. Kriege M., Brekelmans C.T., Boetes C., et al. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer 106 (2006) 2318-2326
16. Komenaka I.K., Ditkoff B.A., Joseph K.A., et al. The development of interval breast malignancies in patients with BRCA mutations. Cancer 100 (2004) 2079-2083
17. Adem C., Reynolds C., Soderberg C.L., et al. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer 97 (2003) 1-11